BILINSKY IGOR 4
4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
IOVANCE (IOVA) COO Igor Bilinsky Receives RSUs; Shares Withheld
What Happened
Igor Bilinsky, Chief Operating Officer of Iovance Biotherapeutics (IOVA), had 31,246 restricted stock units (RSUs) vest on March 5, 2026. The RSUs converted into 31,246 shares (acquired at $0.00 per share as typical for RSU vesting). To satisfy mandatory tax withholding, 16,628 of those shares were withheld by the issuer at an indicated value of $4.58 per share (withholding value ≈ $76,156), leaving Bilinsky with 14,618 shares net.
Key Details
- Transaction date: March 5, 2026; Form 4 filed March 6, 2026 (timely).
- Vesting/Conversion: 31,246 RSUs converted to common stock (transaction code M).
- Tax withholding: 16,628 shares withheld (transaction code F) at $4.58/share = $76,156 (not an open‑market sale).
- Net shares issued to insider: 14,618 shares (31,246 − 16,628).
- Footnotes: Each RSU equals one share; withheld shares are solely for tax obligations; remaining RSUs from the March 5, 2025 grant will vest in equal quarterly installments.
Context
This was a standard RSU vesting and net settlement (company withheld shares to cover taxes), not a cash sale on the open market. For retail investors, vesting/withholding transactions are routine compensation events and do not by themselves indicate buying or selling sentiment.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-03-05+31,246→ 142,394 total - Tax Payment
Common Stock
[F2][F3]2026-03-05$4.58/sh−16,628$76,156→ 125,766 total - Exercise/Conversion
Restricted Stock Units
[F4][F5][F6]2026-03-05−31,246→ 62,504 total→ Common stock (31,246 underlying)
Footnotes (6)
- [F1]Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
- [F2]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
- [F3]Represents common stock remaining after deducting the common stock withheld for taxes.
- [F4]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F5]The remaining RSUs will vest in equal quarterly installments.
- [F6]Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person.